Literature DB >> 10492766

Time to reappearance of malaria parasites following various drug treatment regimens in a holoendemic area of western Kenya.

G D Shanks1, B O Ragama, A J Oloo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10492766     DOI： 10.1016/s0035-9203(99)90031-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  3 in total

1.  Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.

Authors:  Stephan Chalon; M Farouk Chughlay; Nada Abla; Andre Marie Tchouatieu; Amina Haouala; Ben Hutter; Ulrike Lorch; Fiona Macintyre
Journal:  Clin Pharmacol Ther       Date:  2021-09-14       Impact factor: 6.903

2.  Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.

Authors:  Mark E Polhemus; Shon Remich; Bernhards Ogutu; John Waitumbi; Marc Lievens; W Ripley Ballou; D Gray Heppner
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

3.  Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.

Authors:  Geoffrey S Dow; Alan J Magill; Colin Ohrt
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.